More Articles
An advanced artificial intelligence (AI) algorithm examining electrocardiograms (ECG) can help clinicians diagnose and treat hypertrophic cardiomyopathy (HCM), according to a new study published in the Journal of the American…
ACC.22, the annual meeting of the American College of Cardiology, isn’t the only industry conference taking place in early April: EHRA 2022, the yearly get-together hosted by the…
Screening older patients for atrial fibrillation (AFib) during primary care visits provides little value, according to new research published in Circulation.[1]
The study’s authors noted that…
Direct oral anticoagulants (DOACs) may be an effective anticoagulation strategy for atrial fibrillation (AFib) patients who undergo bioprosthetic valve replacement, according to a new meta-analysis published in the American…
Cardiac resynchronization therapy with a defibrillator (CRT-D) is associated with “significant improvements” in mortality and heart failure (HF) hospitalization…
The University of California San Diego Health has debuted a new technology that may offer a better way to assess and treat…
Medtronic has gained an expanded FDA approval for its Freezor and…
Cleveland Clinic shared its annual list of 10 medical innovations expected to make a big impact on patient care in 2022. While the analysis covers multiple areas, including mRNA technology…
The presence of myocardial fibrosis (MF) on cardiac MRI (CMR) can help anticipate adverse…
Abbott announced the world's first patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2 FDA pivotal clinical study. The implant of Abbott's investigational Aveir dual-chamber leadless pacemaker represents a…
Biotricity, a California-based healthcare technology company, has received FDA clearance for its new three-lead electrocardiogram (ECG) and arrhythmia monitoring solution.
The Biotres Cardiac…
Many recovered COVID-19 patients still show signs of right ventricular dysfunction and diastolic dysfunction three months after hospitalization, according to a new study published in the Journal of the…
Patients who receive a secondary prevention implantable cardioverter defibrillator (ICD) may be able to start driving again a little earlier than previously believed, according to a new study…
Sudden cardiac death (SCD) cases are very rarely associated with having sex among younger individuals, according to a new analysis published in JAMA Cardiology.
The study’s authors examined…
Royal Philips has announced its plans to collaborate with the American Heart Association (AHA) to boost awareness about cardiovascular implantable electronic device (CIED) infections.
…
Abbott has received FDA clearance for its new cardiac mapping solution fort the electrophysiology (EP) lab that provides users with 3D representations of the patient’s…
Apixaban is associated with lower rates of major and gastrointestinal bleeding than rivaroxaban in patients with nonvalvular atrial fibrillation (NVAF)…
Direct oral anticoagulants (DOACs) aren’t prescribed to frail atrial fibrillation (AFib) patients as much as they should be, according to a new study published in the Canadian Journal of Cardiology.…
Treatment with metoprolol may benefit patients with obstructive hypertrophic cardiomyopathy (HCM), according to a new study published in the Journal of the American College of Cardiology.…
Implantable cardioverter-defibrillators (ICDs) are underused among female and non-white hypertrophic cardiomyopathy (HCM) patients, according to new research published in Mayo Clinic Proceedings.
…
Risk scores designed to predict atrial fibrillation (AFib) after catheter ablation are largely ineffective, according to new data …